Fundz

Who to call at BridgeBio, and when

Fundz watches for the moments BridgeBio starts buying, and tells you who to reach.

  • An alert the day BridgeBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BridgeBio, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

BridgeBio Pharma Enters Agreement with U.S. Government for Medicine Affordability

Aug 31, 2026

Contract Type

partnership

Palo AltoBiotechnologyHealth CareTherapeutics

Description

On August 31, 2026, BridgeBio Pharma, Inc. announced an agreement with the U.S. government aimed at improving affordability and access to critical medicines for Americans. The agreement specifies a pricing commitment for the company's future medicines while excluding those approved exclusively for orphan indications

Company Information

Company

BridgeBio

Location

Palo Alto, California, United States

About

BridgeBio Oncology Therapeutics (BBOT) has launched with a $200m private financing round, aiming to expedite the development of the company’s precision oncology pipeline and focusing on new cancer treatments.

Related People

Damian
Likely contact at this company
••••••••@••••••••

See Damian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BridgeBio's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

BridgeBio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.